Kazuma Takase

发表

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Y. Funahashi, J. Matsui, Yu Kato, 2018, Cancer science.

Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.

Mark D. Hopkin, D. O'connor, J. Ellard, 2015, Bioorganic & medicinal chemistry letters.

A novel truncated glucagon-like peptide 2 (GLP-2) as a tool for analyzing GLP-2 receptor agonists.

J. Nagakawa, H. Terauchi, K. Tsukahara, 2013, Biomedical research.

Species-specific differences in agonistic activity of ago-allosteric modulators toward glucagon-like peptide 2 receptor.

J. Nagakawa, H. Terauchi, K. Tsukahara, 2012, Biomedical research.

Ago-allosteric modulators of human glucagon-like peptide 2 receptor.

J. Nagakawa, H. Terauchi, K. Tsukahara, 2012, Bioorganic & medicinal chemistry letters.

Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

K. Sawada, K. Okamoto, Kotaro Kodama, 2014, Molecular Cancer Therapeutics.

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease

K. Agarwala, M. Muratani, A. Fukamizu, 2018, Nature Communications.

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.

Masao Iwata, Kiyoshi Okamoto, Yuji Yamamoto, 2013, Cancer letters.

Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway

K. Sawada, M. Uesugi, N. Miyamoto, 2017, Toxicology and applied pharmacology.

Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells.

N. Oku, T. Asai, H. Kikuchi, 2017, International journal of pharmaceutics.

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease

K. Agarwala, M. Muratani, A. Fukamizu, 2018, Nature Communications.

Methodes d'identification des agonistes et des antagonistes gpr83 capables de moduler la fonction regulatrice des lymphocytes t

A. Hamaguchi, Kazuma Takase, T. Seiki, 2006 .

Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma

Y. Funahashi, J. Matsui, K. Nomoto, 2019, Cancer investigation.